SECsense Logo

Hutchmed (China) Limited 2024 Final Results Announcement - Form 6-K Report

$HCM
Form 6-K
Filed on: 2025-02-19
Source
Hutchmed (China) Limited 2024 Final Results Announcement - Form 6-K Report

Here are the key insights extracted from the provided financial report (Form 6-K) for Hutchmed (China) Limited:

  1. Filing Information:
  • Document Type: Form 6-K
  • Filing Date: February 19, 2025
  • Commission File Number: 001-37710
  1. Company Overview:
  • Company Name: Hutchmed (China) Limited
  • Principal Executive Office Address: 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong
  1. Report Purpose:
  • This report is filed by a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
  • It includes announcements related to the notice of the announcement of the 2024 final results.
  1. Exhibits:
  • Exhibit Number: 99.1
  • Description: Announcement relating to the notice of announcement of 2024 final results.
  1. Signature:
  • The report is signed by Johnny Cheng, who holds the title of Chief Financial Officer (CFO).

Overall, this document primarily serves as an official notification related to Hutchmed's upcoming financial results for the year 2024, aligning with regulatory requirements for reporting by foreign private issuers.